This meeting took place in 2014

Here are the related meetings in 2020:
Ubiquitin Biology (X7)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

The Ubiquitin System: From Basic Science to Drug Discovery (A2)

Organizer(s) Ingrid E. Wertz and David Komander
January 7—12, 2014
Big Sky Resort • Big Sky, Montana USA
Discounted Abstract Deadline: Oct 2, 2013
Abstract Deadline: Oct 24, 2013
Scholarship Deadline: Oct 2, 2013
Discounted Registration Deadline: Nov 7, 2013

Sponsored by Cell Research and Genentech, Inc.

Summary of Meeting:
Ubiquitination, the covalent ligation of target proteins by the 76-amino acid protein ubiquitin, regulates the fate and function of the substrate proteins. Aberrant ubiquitination promotes numerous disease states, but the mechanisms by which the ubiquitin system regulates cellular signaling and pathogenesis remain largely unknown. This meeting will: 1) Highlight recent basic science advances in the field of ubiquitin research; 2) Reveal gaps in our understanding of how the ubiquitin system regulates human disease, and how we can best apply our knowledge to answer these questions; and 3) Update attendees on the efficacy of drugs that target the ubiquitin/proteasome system. Initial plenary sessions will focus on the basic science of the ubiquitin system, including lectures describing ubiquitin modifications and the enzymology of the ubiquitin system. The role of ubiquitination in cellular signaling, with a focus on enzyme sub-classes and specific pathways, will next be explored. Workshops highlighting model systems and technological advances used to investigate the ubiquitin system are also incorporated. The meeting will culminate with sessions focused on the role of the ubiquitin system in human disease and as a drug target. The meeting format will encourage interaction between clinicians, translational researchers and basic scientists with interests ranging from the biophysics to the cellular biology of the ubiquitin system. The anticipated outcomes will be increased understanding of the interrelated roles that the ubiquitin system plays in normal homeostasis and in disease, and of the next steps required to target the ubiquitin system for patient benefit.

View Meeting Program


Keystone Symposia Future of Science Fund Scholarship Recipients

Sakshi Arora
National Institute of Immunology, India

Marie-Luise Lubos
Institute of Infectiology, University of Muenster, Germany

Maureen Spit
University Medical Center Utrecht, Netherlands

Jennifer Ward
Imperial College London, UK

National Institute of General Medical Sciences (NIGMS) Ancillary Training Program Scholarship Recipients

Pearl N. Magala
Johns Hopkins University, USA

Shameika Wilmington
Northwestern University/University of Texas at Austin, USA